Muscle eye brain disease (MEB) is a disorder that is inherited in an autosomal recessive manner through mutations in the POMGNT1 gene. MEB is a form of congenital muscular dystrophy, and people with this disorder typically have very little control over their muscle movement. Other symptoms of MEB include vision impairments such as myopia and glaucoma, as well as brain abnormalities leading to mental disabilities and facial deformities. Muscle eye brain disease is very rare, and the severity varies on an individual basis, but most patients die between the ages of 6 and 16. However, there is currently no successful treatment for this disorder, and doctors focus mainly on preserving whatever functions the patient still has.
Muscle Eye Brain Disease Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Muscle Eye Brain Disease below!
For more information on how to use Laverne, please read the How to Guide.
We have 233 products for the study of Muscle Eye Brain Disease that can be applied to Chromatin Immunoprecipitation, Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Muscle Eye Brain Disease is also known as muscle-eye-brain disease, muscle eye brain disease, meb.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.